Quinine copolymer reporters promote efficient intracellular DNA delivery and illuminate a protein-induced unpackaging mechanism
- PMID: 33318196
- PMCID: PMC7777095
- DOI: 10.1073/pnas.2016860117
Quinine copolymer reporters promote efficient intracellular DNA delivery and illuminate a protein-induced unpackaging mechanism
Abstract
Polymeric vehicles that efficiently package and controllably release nucleic acids enable the development of safer and more efficacious strategies in genetic and polynucleotide therapies. Developing delivery platforms that endogenously monitor the molecular interactions, which facilitate binding and release of nucleic acids in cells, would aid in the rational design of more effective vectors for clinical applications. Here, we report the facile synthesis of a copolymer containing quinine and 2-hydroxyethyl acrylate that effectively compacts plasmid DNA (pDNA) through electrostatic binding and intercalation. This polymer system poly(quinine-co-HEA) packages pDNA and shows exceptional cellular internalization, transgene expression, and low cytotoxicity compared to commercial controls for several human cell lines, including HeLa, HEK 293T, K562, and keratinocytes (N/TERTs). Using quinine as an endogenous reporter for pDNA intercalation, Raman imaging revealed that proteins inside cells facilitate the unpackaging of polymer-DNA complexes (polyplexes) and the release of their cargo. Our work showcases the ability of this quinine copolymer reporter to not only facilitate effective gene delivery but also enable diagnostic monitoring of polymer-pDNA binding interactions on the molecular scale via Raman imaging. The use of Raman chemical imaging in the field of gene delivery yields unprecedented insight into the unpackaging behavior of polyplexes in cells and provides a methodology to assess and design more efficient delivery vehicles for gene-based therapies.
Keywords: biomaterial; drug delivery; gene editing; gene therapy; polymer.
Copyright © 2020 the Author(s). Published by PNAS.
Conflict of interest statement
Competing interest statement: A US Provisional Application (62/536,427) on this work has been filed.
Figures
References
-
- Foldvari M., et al. , Non-viral gene therapy: Gains and challenges of non-invasive administration methods. J. Control. Release 240, 165–190 (2016). - PubMed
-
- Xu X., et al. , Delivery of CRISPR/Cas9 for therapeutic genome editing. J. Gene Med. 21, e3107 (2019). - PubMed
-
- Ke L., Cai P., Wu Y.-L., Chen X., Polymeric nonviral gene delivery systems for cancer immunotherapy. Adv. Ther. 3, 1900213 (2020).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
